lorazepam and raclopride

lorazepam has been researched along with raclopride in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Brodie, JD; Dewey, SL; Ferrieri, RA; King, PT; Logan, J; MacGregor, RR; Martin, TP; Smith, GS; Wolf, AP; Yu, DW	1
Hietala, J; Kuoppamäki, M; Lehikoinen, P; Någren, K; Syvälahti, E	1

Trials

1 trial(s) available for lorazepam and raclopride

Article	Year
Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man--a positron emission tomography study. Psychopharmacology, 1997, Volume: 132, Issue:4 Topics: Adult; Carbon Radioisotopes; Cross-Over Studies; Double-Blind Method; GABA Modulators; Humans; Lorazepam; Male; Neostriatum; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed	1997

Article

Year

Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man--a positron emission tomography study.

Psychopharmacology, 1997, Volume: 132, Issue:4

Topics: Adult; Carbon Radioisotopes; Cross-Over Studies; Double-Blind Method; GABA Modulators; Humans; Lorazepam; Male; Neostriatum; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed

1997

Other Studies

2 other study(ies) available for lorazepam and raclopride

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1992, Volume: 12, Issue:10 Topics: Aminocaproates; Animals; Brain; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine; Female; gamma-Aminobutyric Acid; Lorazepam; Neurotransmitter Agents; Papio; Raclopride; Salicylamides; Tomography, Emission-Computed; Vigabatrin	1992

Article

Year

QSAR model for drug human oral bioavailability.

Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000

GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 1992, Volume: 12, Issue:10

Topics: Aminocaproates; Animals; Brain; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine; Female; gamma-Aminobutyric Acid; Lorazepam; Neurotransmitter Agents; Papio; Raclopride; Salicylamides; Tomography, Emission-Computed; Vigabatrin

1992